HLB Co., Ltd. HLB Co., Ltd.

HLB Co., Ltd.

028300

Peringkat dalam Saham #3920
HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and... HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and naval construction. In South Korea, its maritime division produces and distributes a diverse range of lifeboats, catering to offshore platforms, drilling vessels, and passenger cruise liners. Its offerings include traditional, free-fall, and rescue boat designs. Beyond lifeboats, HLB's product portfolio extends to marine and yacht engines, hooks, and a variety of specialized vessels such as rigid inflatable (RIB), patrol, fishing, aluminum, and leisure boats, as well as fishery inspection ships and general safety equipment. The company further offers comprehensive support services, including inspection and repair of lifeboats and davits, service engineering training, and the provision of spare parts. On the pharmaceutical front, HLB is engaged in the development of Riboseranib, a targeted anti-cancer agent, and Apilia, a treatment specifically for ovarian cancer. Established in 1975, HLB Co., Ltd. is headquartered in Ulsan, South Korea.
Harga Saham
$31.27
Kapitalisasi Pasar
$4.16B
Perubahan (1 hari)
6.78%
Perubahan (1 tahun)
1.26%
Negara
KR
Perdagangan HLB Co., Ltd. (028300)

Kategori

Healthcare
Riwayat harga saham HLB Co., Ltd. (028300)
Harga penutupan tertinggi: $29.89 pada 2026-10-01

Harga penutupan terendah: $1.36 pada 2008-12-01
Riwayat harga saham HLB Co., Ltd. dari 2008 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) 0.63%
2025 -33.96%
2024 57.41%
2023 40.26%
2022 -17.38%
2021 -30.97%
2020 8.36%
2019 23.72%
2018 110.61%
2017 199.59%
2016 -34.89%
2015 161.99%
2014 189.01%
2013 -5.55%
2012 30.30%
2011 0.39%
2010 -50.22%
2009 13.14%
2008 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$536.13 25.72%
US
$200.12 645.31%
US
$137.83 -3.78%
AU
$291.76 2.51%
BE
$880.01 8.09%
NL